CompletedNot Applicable

Effectiveness of a Robot Assisted Tenodeis-grip Neurorehabilitation

Taiwan38 participantsStarted 2018-12-03

Plain-language summary

In the proposed study, the investigators assumed that using robot assisted tenodesis-grip training providing high does assisted grip movement may do the effects on motor shaping and greater brain priming for hand paresis of the stroke patients. The specific aim of this study is to examine the difference in the treatment effects between the combination of robot assisted tenodesis-grip training with task-oriented training and combination of traditional occupational therapy with task-oriented training on the motor, sensation, hand performance of the stroke patients. The expected outcomes of this research are to help the clinicians understand the training mechanism and effects of robot assisted tenodesis-grip training on functional performance of upper extremity for unilateral stroke patients.

Who can participate

Age range

20 Years – 80 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

. Clinical diagnosis of stroke with unilateral side involved;
. Stroke at least 7 days before the start of the first assessment session;
. A score of Mini-mental state examination greater than 24 for proving higher mental function;
. Premorbid right-handedness.

Exclusion criteria

. Uncontrolled hypertension;
. Major cognitive-perceptual deficit;
. Other brain disease.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Change in the result of Fugl-Meyer assessment for UE motor function

Timeframe: baseline, 6 weeks and 18 weeks

Change in the result of Modified Ashworth scale (MAS)

Timeframe: baseline, 6 weeks and 18 weeks

Change in the result of Box and blocks test

Timeframe: baseline, 6 weeks and 18 weeks

Change in the result of Semmes-Weinstein monofilament (SWM) test

Timeframe: baseline, 6 weeks and 18 weeks

Change in the result of Motor Activity Log

Timeframe: baseline, 6 weeks and 18 weeks

Trial details

NCT IDNCT03713476

SponsorNational Cheng-Kung University Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-03-20

View on ClinicalTrials.gov More Rehabilitation, Tenodesis, Stroke trials

Plain-language summary

Who can participate

Age range

20 Years – 80 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

. Clinical diagnosis of stroke with unilateral side involved;
. Stroke at least 7 days before the start of the first assessment session;
. A score of Mini-mental state examination greater than 24 for proving higher mental function;
. Premorbid right-handedness.

Exclusion criteria

. Uncontrolled hypertension;
. Major cognitive-perceptual deficit;
. Other brain disease.

What they're measuring

Change in the result of Fugl-Meyer assessment for UE motor function

Timeframe: baseline, 6 weeks and 18 weeks

Change in the result of Modified Ashworth scale (MAS)

Timeframe: baseline, 6 weeks and 18 weeks

Change in the result of Box and blocks test

Timeframe: baseline, 6 weeks and 18 weeks

Change in the result of Semmes-Weinstein monofilament (SWM) test

Timeframe: baseline, 6 weeks and 18 weeks

Change in the result of Motor Activity Log

Timeframe: baseline, 6 weeks and 18 weeks